Brief: MGC Pharmaceuticals Receives Order For $1M From AMC Pharma
07/07/2023 01:59
July 7 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* RECEIVED AN ORDER FOR US$1M FROM AMC PHARMA TO PRODUCE
ARTEMIC
Source text for Eikon: ID:nASX1z51xq
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program